Investegate announcements from Orphalan, Orphalan announces FDA approval of Cuvrior™ for the treatment of adult patients with stable Wilson’s disease who are de-coppered and tolerant to penicillamine
Orphalan announces FDA approval of Cuvrior for the treatment of adult patients with stable Wilson's disease who are de-coppered and tolerant to penicillamine Paris, France 2 May 2022 - Orphalan
Orphalan Announces Positive Top Line Data with Trientine Tetrahydrochloride for Maintenance apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.